Trial intelligence / Profile preview

Valproic Acid in Relapsed/Refractory CLL

NCT00810680Phase 2Unknown

Sponsor
AIIMS New Delhi
Start
Sep 2008
Primary completion
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of valproic acid in chronic lymphocytic leukemia (CLL), sponsored by AIIMS New Delhi. Status: unknown.

02

Drugs

valproic acid
03

Conditions

chronic lymphocytic leukemia (CLL)

Beyond the preview

Go deeper on NCT00810680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00810680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call